Riedler L
Fortschr Med. 1976 May 6;94(13):761-4.
The course of treatment with polychemotherapy for the progressed and metastasized breast-carcinoma is discussed. The therapy with cytostatics must be continued for the patients entire life. A sample of 27 patients from the Chir; Univ.-Klinik Innsbruck with a course of treatment lasting from 15 to 29 months (October 1973 resp; December 1974 to February 1976) showed a success rate of 81%.
讨论了多药化疗对进展期和转移性乳腺癌的治疗过程。细胞抑制剂治疗必须持续患者的一生。来自因斯布鲁克大学临床医院的27名患者样本,治疗疗程从15个月至29个月(分别为1973年10月;1974年12月至1976年2月),成功率为81%。